BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/24/2020 12:41:21 PM | Browse: 730 | Download: 2249
 |
Received |
|
2020-06-23 05:21 |
 |
Peer-Review Started |
|
2020-06-23 05:22 |
 |
First Decision by Editorial Office Director |
|
2020-07-30 23:04 |
 |
Return for Revision |
|
2020-07-30 23:04 |
 |
Revised |
|
2020-08-10 14:37 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2020-09-02 12:49 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2020-09-02 18:07 |
 |
Articles in Press |
|
2020-09-02 18:07 |
 |
Edit the Manuscript by Language Editor |
|
2020-09-08 14:26 |
 |
Typeset the Manuscript |
|
2020-11-20 17:14 |
 |
Publish the Manuscript Online |
|
2020-11-24 12:41 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Real impact of tumor marker AFP and PIVKA-Ⅱ in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Kazuo Tarao, Akito Nozaki, Hirokazu Komatsu, Tatsuji Komatsu, Masataka Taguri, Katsuaki Tanaka, Makoto Chuma, Kazushi Numata and Shin Maeda |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| The Kanagawa Association of Medical and Dental Practitioners |
|
|
| Corresponding Author |
Kazuo Tarao, MD, PhD, Director, Director, Department of Gastroenterology, Tarao’s Gastroenterological Clinic, 2-58-6, Taiyo Building Futamatagawa, Asahi-ku, Yokohama 241-0821, Japan. duoluoweih7@gmail.com |
| Key Words |
Hepatocellular carcinoma; AFP; PIVKA-Ⅱ; Barcelona clinical stage; Tumor markers; |
| Core Tip |
In hepatocellular carcinoma, detection and treatment prior to growth 2 cm (Barcelona stage 0) are relevant as a larger tumor size is more frequently associated with microvascular invasion and / or satellites. We surveyed the real impact of the tumor markers AFP or PIVKA-Ⅱ in detecting very small hepatocellular carcinoma with a large number of cases (≤ 2 cm in diameter 394 cases), and found that in AFP 50.5% and in PIVKA-Ⅱ 68.8% showed normal levels. Moreover, 36.4% of the patients showed normal levels in both AFP and PIVKA-Ⅱ. In the surveillance of very small hepatocellular carcinoma nodules the tumor markers are not so useful. |
| Publish Date |
2020-11-24 12:41 |
| Citation |
Tarao K, Nozaki A, Komatsu H, Komatsu T, Taguri M, Tanaka K, Chuma M, Numata K, Maeda S. Real impact of tumor marker AFP and PIVKA-Ⅱ in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases. World J Hepatol 2020; 12(11): 1046-1054 |
| URL |
https://www.wjgnet.com/1948-5182/full/v12/i11/1046.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v12.i11.1046 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.